Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis

By sjmartinez • April 18, 2024

Beswick DM, Liu CM, Overdevest JB, Zemke A, Khatiwada A, Gudis DA, Miller JE, Kimple A, Tervo JP, DiMango E, Goralski JL, Keating C, Senior B, Stapleton AL, Eshaghian PH, Mace JC, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Getz AE, Hwang PH, Khanwalker A, Lee JT, Li DA, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Turner GA, Wang MB, Saavedra MT, Taylor Cousar JL. Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis. Laryngoscope. 2024 Apr 18. doi: 10.1002/lary.31438. Epub ahead of print. PMID: 38634358.

Tags: CFTR modulator therapy, chronic rhinosinusitis, cystic fibrosis, elexacaftor/tezacaftor/ivacaftor, minimal clinically important difference, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Tools for endoscopic management of benign luminal GI strictures

ASGE Technology Committee; Akshintala VS, Shahnavaz N, Abdi M, Chen D, Chen YI, Das KK, Desilets D, Girotra M, Vinsard DG, Leung G, Mishra G,[...]

Dynamics of Th1/Th17 responses and antimicrobial pathways in leprosy skin lesions

Andrade PR, Ma F, Lu J, de Anda J, Lee EY, Agak GW, Dobry CJ, de Andrade Silva BJ, Teles RM, Mansky LA, Perrie J,[...]

Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applications

Chan AA, Caron C, Navarrete M, Lee CK, Noguti J, Bui JD, Lee DJ. Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a[...]